Opendata, web and dolomites
H2020 projects about "hepatocellular"
The page lists 33 projects related to the topic "hepatocellular".
| # | |||
|---|---|---|---|
| 1 | EPoS | Elucidating Pathways of Steatohepatitis | 2015 |
| 2 | COLOStage | COLOStage : A new prognosis test for the prediction of metastasis in Colorectal Cancer and Hepatocellular Carcinoma | 2015 |
| 3 | mini-liver SCCS | Human “mini-liver” stem cell culture systems: from mechanisms behind liver cancer origin and recurrence to new therapeutic treatments | 2016 |
| 4 | TARGEPILIVER | Characterization of Key Epigenetic Targets in Hepatic Fibrosis and Hepatocellular Carcinoma Development. Generation of New Antifibrotic and Antitumoral Drugs. | 2015 |
| 5 | HepatoRiSK | A new tumor suppressor role for RSK2 in hepatocellular carcinoma | 2015 |
| 6 | HEPCIR | Cell circuits as targets and biomarkers for liver disease and cancer prevention | 2016 |
| 7 | HEP-CAR | Mechanisms underlying hepatocellular carcinoma pathogenesis and impact of co-morbidities. | 2016 |
| 8 | ChiLTERN | Children’s Liver Tumour European Research Network | 2016 |
| 9 | HepatoMetaboPath | Cellular and molecular mechanisms of metabolic immune activation triggering non-alcoholic steatohepatitis (NASH) and HCC | 2016 |
| 10 | HiPerNav | High Performance Soft-tissue Navigation | 2016 |
| 11 | Foie Gras | Bioenergetic Remodeling in the Pathophysiology and Treatment of Non-Alcoholic Fatty Liver Disease | 2017 |
| 12 | mtFOIE GRAS | mitoFOIE GRAS: Non-invasive Profiling of Mitochondrial Function in Non-Alcoholic Fatty Liver Disease | 2017 |
| 13 | OPN-Can | Investigating the role of OPN-CD44 in mechanosensitive tumour invasion using biomimetic models | 2017 |
| 14 | Hepatocarcinoma IVM | Spatiotemporal dynamics of CD8+ T cell responses to hepatocellular carcinoma | 2017 |
| 15 | HEGEMONIC | HEpatocellular carcinoma GErmline MutatiONs ImpaCt (HEGEMONIC) | 2017 |
| 16 | FATE | Functional Biology of Hepatic CD8+ T cells | 2017 |
| 17 | HEPASPHER | Mimicking liver disease and regeneration in vitro for drug development and liver transplantation | 2017 |
| 18 | ADVaNCE | ADVerse outcome Network for non-mutagenic CarcinogEns | 2017 |
| 19 | HepaCheC | HepaCheC - an in vitro diagnostic assay for the early detection of liver cancer | 2018 |
| 20 | PhaseControl | How cellular suicide programmes control phase transitions in fatty liver disease and liver cancer | 2018 |
| 21 | mTORmorS | Role of mTOR signaling dysregulation in the tumor suppressor networks in hepatocellular carcinoma | 2019 |
| 22 | HepatoPredict | A decision tool for Liver Transplantation based on molecular signature | 2018 |
| 23 | HIPShot | HBV GenetIc and Proteomic Screen | 2019 |
| 24 | COCLICAN | COllaborative Consortium for the early detection of LIver CANcer | 2018 |
| 25 | RNADIAGON | Excellence in research and development of non-coding RNA DIAGnostics in ONcology | 2019 |
| 26 | RxmiRcanceR | Tumor suppressive microRNAs for cancer therapy | 2018 |
| 27 | ESCALON | European-Latin American network for the assessment of biomarkers to predict and diagnose hepatobiliary malignancies and characterization of risk factors for cancer development | 2019 |
| 28 | HEPCAN | A Humanized Monoclonal Anti-Claudin1 Antibody (anti-CLDN1 mAb) for Treatment of Hepatocellular Carcinoma (HCC) | 2019 |
| 29 | CSI AurkA-MYC | Conformational Shift Inducers (CSI): An atomistic level investigation of Aurora kinase A (AurkA)–MYC interaction and its distortion by CSI compounds | 2019 |
| 30 | MyeFattyLiver | Unravelling the heterogeneity and functions of hepatic myeloid cells in Non-Alcoholic Fatty Liver Disease | 2019 |
| 31 | inhibiTOR | Novel selective mTORC1 inhibitors | 2020 |
| 32 | M6AQuantKit | Development and commercialization of kit for quantitative interrogation of a key RNA modification | 2020 |
| 33 | ONCO-VAX | A multifaceted cancer immunotherapy based on an immune checkpoint-modulating chimeric oncolytic virus vector in combination with a dendritic cell vaccine | 2020 |